A developer of novel anti-infective drug candidates targeting specific pathogens that cause serious infections and diseases, including C. difficile, constipation-predominant irritable bowel syndrome, Pertussis, Acinetobacter and multiple sclerosis
Managing four global allocation portfolios at GFG Capital with assets over $1 billion. Managed a portion of the Stetson University endowment as a trustee and equity/fixed income analyst. Small Cap analyst KCM.
I'm,firstly a Forex trader (since 2010 year) but also interested in other markets.My trading style is combination between fundamental and technical analysis.I'm a student of economics,course finance and banking.